 |
 Video: What is a Stock Split?
|
|
|
| Immunocore Holdings is a late-stage biotechnology company focusing on the development of a class of T cell receptors, or TCR, bispecific immunotherapies called ImmTAX, Immune mobilizing monoclonal TCRs Against X disease, designed to treat a range of diseases, including cancer, infectious and autoimmune. Co.'s platforms include: ImmTAC, which focuses on the treatment of solid tumors; ImmTAV, which includes IMC-I109V, its ImmTAV molecule targeting a conserved hepatitis B virus envelope antigen; and ImmTAAI, which utilizes its ImmTAX platform to generate product candidates designed to provide targeted immunosuppression for the treatment of autoimmune diseases. According to our Immunocore Holdings PLC stock split history records, Immunocore Holdings PLC has had 0 splits. | |
|
Immunocore Holdings PLC (IMCR) has 0 splits in our Immunocore Holdings PLC stock split history database.
Looking at the Immunocore Holdings PLC stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Immunocore Holdings PLC shares, starting with a $10,000 purchase of IMCR, presented on a split-history-adjusted basis factoring in the complete Immunocore Holdings PLC stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
02/08/2021 |
|
| End date: |
04/24/2024 |
|
| Start price/share: |
$56.34 |
|
| End price/share: |
$58.47 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
3.78% |
|
| Average Annual Total Return: |
1.16% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$10,376.61 |
|
| Years: |
3.21 |
|
|
|
|
|
